Liquid Biopsy Market Impacted by COVID-19, Market to Remain Dormant in Near Term, Projects FMI 2022 -2031

 As per a recent market survey by ESOMAR-certified consulting firm Future Market Insights (FMI), the global Liquid Biopsy Market Size is expected to reach a market valuation of US$ 1,026 Mn in 2021.

  • Based on markers, circular tumor cells (CTC) are poised to emerge dominant in the forthcoming years.
  • Blood samples will emerge as the most preferred sample type
  • The U.S. will showcase high growth during the forecast period, due to the presence of major liquid biopsy product manufacturers.
  • The U.K. will emerge as an avenue for product innovations and development, further solidifying growth prospects.
  • Japan is anticipated to witness upswings in sales, owing to government-led cancer research initiatives.
  • India is expected to showcase high demand for liquid biopsy products, owing to the increased funding by government and expansion of healthcare infrastructure.
  • Germany, India, and China will emerge as high growth potential markets, with increasing investments by the government for improving the healthcare infrastructure, which will create attractive opportunities to global biotech players for market expansion.
  • CTCs (Circulating Tumour Cells)
  • ctNA (Circulating tumor Nucleic Acids)
  • Exosomes
  • Blood
  • Urine
  • Others (Plasma, Saliva, CSF)
  • Lung Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Leukemia
  • Hospitals
  • Cancer Institutes
  • Academic Institutes
  • Diagnostic Centers
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East & Africa

Comments

Popular posts from this blog

Healthy Fat-Free Snacks Market 2022 Outlook, Current and Future Industry Landscape Analysis 2031

Neurointerventional Devices Market Witness a Spike in Growth Pace Recent Improvements in Pricing Models: FMI

Hyperbaric Oxygen Therapy Devices Market Witness a Spike in Growth Pace Recent Improvements in Pricing Models: FMI